Related Experiment Video
Updated: May 25, 2026
Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells
Published on: March 28, 2013
UCP2 inhibits ROS-mediated apoptosis in A549 under hypoxic conditions
Sanming Deng1, Ye Yang, Yong Han
1Department of Thoracic Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, Shaanxi Province, China.
Abstract:
The Crosstalk between a tumor and its hypoxic microenvironment has become increasingly important. However, the exact role of UCP2 function in cancer cells under hypoxia remains unknown. In this study, UCP2 showed anti-apoptotic properties in A549 cells under hypoxic conditions. Over-expression of UCP2 in A549 cells inhibited reactive oxygen species (ROS) accumulation (P<0.001) and apoptosis (P<0.001) compared to the controls when the cells were exposed to hypoxia. Moreover, over-expression of UCP2 inhibited the release of cytochrome C and reduced the activation of caspase-9. Conversely, suppression of UCP2 resulted in the ROS generation (P = 0.006), the induction of apoptosis (P<0.001), and the release of cytochrome C from mitochondria to the cytosolic fraction, thus activating caspase-9. These data suggest that over-expression of UCP2 has anti-apoptotic properties by inhibiting ROS-mediated apoptosis in A549 cells under hypoxic conditions.
Insights
Uncoupling protein 2 (UCP2) exhibits anti-apoptotic effects in lung cancer cells under hypoxia. Overexpression of UCP2 inhibits reactive oxygen species (ROS) accumulation and cell death, suggesting a protective role.
Area of Science:
- Cell Biology
- Cancer Research
- Biochemistry
Background:
- The tumor microenvironment, particularly hypoxia, significantly influences cancer progression.
- The specific role of uncoupling protein 2 (UCP2) in cancer cells under hypoxic conditions is not well understood.
Purpose of the Study:
- To investigate the function of UCP2 in A549 lung cancer cells exposed to hypoxia.
- To determine the impact of UCP2 on apoptosis and reactive oxygen species (ROS) generation under hypoxic stress.
Main Methods:
- Overexpression and suppression of UCP2 in A549 cells.
- Exposure of cells to hypoxic conditions.
- Measurement of reactive oxygen species (ROS) accumulation.
- Assessment of apoptosis, cytochrome C release, and caspase-9 activation.
Main Results:
- UCP2 overexpression inhibited ROS accumulation (P<0.001) and apoptosis (P<0.001) in A549 cells under hypoxia.
- UCP2 overexpression reduced cytochrome C release and caspase-9 activation.
- UCP2 suppression led to increased ROS generation (P=0.006), apoptosis (P<0.001), and cytochrome C release, activating caspase-9.
Conclusions:
- UCP2 demonstrates anti-apoptotic properties in A549 cells under hypoxic conditions.
- UCP2 inhibits apoptosis by mitigating ROS accumulation in a hypoxic cancer cell model.
